“…Additional work is warranted to substantiate these findings. Other examples of potential stroke biomarkers include total infarct volume [195], white matter tract injury [20–22, 138, 196], cortical activation [42, 52, 91, 175, 138, 197, 198] and connectivity [139, 137, 145, 147, 177, 138, 199], and genetic polymorphisms derived from simple blood tests [15, 16, 200]. These measures may serve an important role in guiding treatment, stratifying subjects in intervention studies, and ultimately predicting functional outcome and response to therapy.…”